Code Ocean Selected by Lantern Pharma to Power A.I. and Computational Biology Research & Data-Driven Oncology Drug Development Collaborations

/PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform...

Related Keywords

Dallas ,Texas ,United States ,Johns Hopkins ,Simon Adar ,Georgetown University ,National Cancer Institute ,Exchange Commission On ,Twitter ,Securities Exchange ,Fox Chase Cancer Center ,Lantern Pharma ,Code Ocean ,Panna Sharma ,Compute Capsules ,Securities Act ,Securities Exchange Act ,Risk Factors ,Annual Report ,Exchange Commission ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,Artificial Intelligence ,Contracts ,